COVID-19 vaccine for children
Scientists of the National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya have obtained patent No. 2761904 for a technical solution related to the use of a vaccine against the SARS-CoV-2 virus in children over a month old.
The patented solution consists of the use of an immunobiological agent that ensures the development of humoral and cellular immune responses against the SARS-CoV-2 virus in children older than 1 month.
Related news
Rospatent Presents Reports of 3D and Blockchain Task Forces at the Committee on WIPO Standards
Celebrating and Empowering IP Examiners
Rospatent and WIPO Launch Joint Seminar Series for Women Entrepreneurs, Researchers, Innovators, and SMEs Across Russia
Russia and Saudi Arabia Strengthen Strategic Partnership in IP